Skip to Main content Skip to Navigation
Journal articles

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.

Abstract : The 2015 Global Meningococcal Initiative (GMI) meeting discussed the global importance of meningococcal disease (MD) and its continually changing epidemiology. Areas covered: Although recent vaccination programs have been successful in reducing incidence in many countries (e.g. Neisseria meningitidis serogroup [Men]C in Brazil, MenA in the African meningitis belt), new clones have emerged, causing outbreaks (e.g. MenW in South America, MenC in Nigeria and Niger). The importance of herd protection was highlighted, emphasizing the need for high vaccination uptake among those with the highest carriage rates, as was the need for boosters to maintain individual and herd protection following decline of immune response after primary immunization. Expert commentary: The GMI Global Recommendations for Meningococcal Disease were updated to include a recommendation to enable access to whole-genome sequencing as for surveillance, guidance on strain typing to guide use of subcapsular vaccines, and recognition of the importance of advocacy and awareness campaigns.
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-02013240
Contributor : Muhamed-Kheir Taha <>
Submitted on : Sunday, February 10, 2019 - 5:27:25 PM
Last modification on : Monday, July 20, 2020 - 1:06:06 PM

Links full text

Identifiers

Collections

Citation

Ray Borrow, Pedro Alarcón, Josefina Carlos, Dominique Caugant, Hannah Christensen, et al.. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.. Expert Review of Vaccines, Expert Reviews (formerly Future Drugs), 2017, 16 (4), pp.313-328. ⟨10.1080/14760584.2017.1258308⟩. ⟨pasteur-02013240⟩

Share

Metrics

Record views

133